NEW YORK (
) is trading at unusually high volume Monday with 1.5 million shares changing hands. It is currently at 4.4 times its average daily volume and trading up 28 cents (+3.7%) at $8.14 as of 1:11 p.m. ET.
Endologix has a market cap of $440 million and is part of the
industry. Shares are up 5.7% year to date as of the close of trading on Thursday.
Endologix, Inc. develops, manufactures, markets, and sells minimally invasive treatments for aortic disorders. Its flagship product, the Powerlink System, is an endovascular stent graft for the treatment of abdominal aortic aneurysms, a weakening of the wall of the aorta, an artery in the body. The company has a P/E ratio of 60.4, above the average health services industry P/E ratio of 37.4 and above the S&P 500 P/E ratio of 16.7.
TheStreet Ratings rates Endologix as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, premium valuation and feeble growth in the company's earnings per share. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from